Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · November 19, 2023

Effect of Vedolizumab Use on Extraintestinal Manifestations in Patients With IBD

Inflammatory Bowel Diseases

 

Additional Info

Disclosure statements are available on the authors' profiles:

Inflammatory Bowel Diseases
Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study
Inflamm. Bowel Dis. 2023 Nov 02;29(11)1713-1722, U Kopylov, J Burisch, S Ben-Horin, F Braegger, A Fernández-Nistal, N Lara, HS Heinrich, SR Vavricka

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading